379 related articles for article (PubMed ID: 9108085)
41. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.
Rousset F; Garcia E; Banchereau J
J Exp Med; 1991 Mar; 173(3):705-10. PubMed ID: 1705282
[TBL] [Abstract][Full Text] [Related]
42. Antigen concentration determines helper T cell subset participation in IgE antibody responses.
Marcelletti JF; Katz DH
Cell Immunol; 1992 Sep; 143(2):405-19. PubMed ID: 1387349
[TBL] [Abstract][Full Text] [Related]
43. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
[TBL] [Abstract][Full Text] [Related]
44. The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice.
Johnson-Léger C; Hasbold J; Holman M; Klaus GG
J Immunol; 1997 Aug; 159(3):1150-9. PubMed ID: 9233608
[TBL] [Abstract][Full Text] [Related]
45. Infection with Nippostrongylus brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin 4 production by non-B, non-T cells.
Conrad DH; Ben-Sasson SZ; Le Gros G; Finkelman FD; Paul WE
J Exp Med; 1990 May; 171(5):1497-508. PubMed ID: 2332730
[TBL] [Abstract][Full Text] [Related]
46. Central role for TCR/CD3 ligation in the differentiation of CD4+ T cells toward A Th1 or Th2 functional phenotype.
Röcken M; Müller KM; Saurat JH; Müller I; Louis JA; Cerottini JC; Hauser C
J Immunol; 1992 Jan; 148(1):47-54. PubMed ID: 1345789
[TBL] [Abstract][Full Text] [Related]
47. Interferon-gamma- and interleukin-4-targeted gene therapy for atopic allergic disease.
Kang KW; Kim TS; Kim KM
Immunology; 1999 Jul; 97(3):462-5. PubMed ID: 10447768
[TBL] [Abstract][Full Text] [Related]
48. A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma.
Ahn HJ; Maruo S; Tomura M; Mu J; Hamaoka T; Nakanishi K; Clark S; Kurimoto M; Okamura H; Fujiwara H
J Immunol; 1997 Sep; 159(5):2125-31. PubMed ID: 9278298
[TBL] [Abstract][Full Text] [Related]
49. A new multivalent B cell activation model--anti-IgD bound to Fc gamma RI: properties and comparison with CD40L-mediated activation.
Cho S; Conrad DH
Int Immunol; 1997 Feb; 9(2):239-48. PubMed ID: 9040006
[TBL] [Abstract][Full Text] [Related]
50. Cord blood B cells are mature in their capacity to switch to IgE-producing cells in response to interleukin-4 in vitro.
Pastorelli G; Rousset F; Pène J; Peronne C; Roncarolo MG; Tovo PA; de Vries JE
Clin Exp Immunol; 1990 Oct; 82(1):114-9. PubMed ID: 2119917
[TBL] [Abstract][Full Text] [Related]
51. Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production.
Peng X; Kasran A; Warmerdam PA; de Boer M; Ceuppens JL
Eur J Immunol; 1996 Jul; 26(7):1621-7. PubMed ID: 8766570
[TBL] [Abstract][Full Text] [Related]
52. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer.
Mattner F; Fischer S; Guckes S; Jin S; Kaulen H; Schmitt E; Rüde E; Germann T
Eur J Immunol; 1993 Sep; 23(9):2202-8. PubMed ID: 8103745
[TBL] [Abstract][Full Text] [Related]
53. Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody.
Finkelman FD; Urban JF; Beckmann MP; Schooley KA; Holmes JM; Katona IM
Int Immunol; 1991 Jun; 3(6):599-607. PubMed ID: 1888709
[TBL] [Abstract][Full Text] [Related]
54. Regulation of interferon-gamma production by IL-12 and IL-18.
Okamura H; Kashiwamura S; Tsutsui H; Yoshimoto T; Nakanishi K
Curr Opin Immunol; 1998 Jun; 10(3):259-64. PubMed ID: 9638361
[TBL] [Abstract][Full Text] [Related]
55. Suppression by IL-2 of IgE production by B cells stimulated by IL-4.
Miyajima H; Hirano T; Hirose S; Karasuyama H; Okumura K; Ovary Z
J Immunol; 1991 Jan; 146(2):457-62. PubMed ID: 1824774
[TBL] [Abstract][Full Text] [Related]
56. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
57. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells.
Punnonen J; de Vries JE
J Immunol; 1994 Feb; 152(3):1094-102. PubMed ID: 7507958
[TBL] [Abstract][Full Text] [Related]
58. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes.
Kiniwa M; Gately M; Gubler U; Chizzonite R; Fargeas C; Delespesse G
J Clin Invest; 1992 Jul; 90(1):262-6. PubMed ID: 1353081
[TBL] [Abstract][Full Text] [Related]
59. IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma.
Thyphronitis G; Tsokos GC; June CH; Levine AD; Finkelman FD
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5580-4. PubMed ID: 2546158
[TBL] [Abstract][Full Text] [Related]
60. The TLR7 agonist imiquimod selectively inhibits IL-4-induced IgE production by suppressing IgG1/IgE class switching and germline ε transcription through the induction of BCL6 expression in B cells.
Yoon HK; Shim YS; Kim PH; Park SR
Cell Immunol; 2019 Apr; 338():1-8. PubMed ID: 30850088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
